Spanish food company Natraceutical has bought UK rival Braes Group for €80m (US$102.1m) as the first step in its international expansion strategy which includes the acquisition of complementary businesses.
Go deeper with GlobalData
Valencia-based Natraceutical bought the firm from British private equity group 3i. It plans to finance the deal with its own cash flow and through an undisclosed share offer.
London-based Braes owns the Swiss-based biotech concerns Obipektin and Spreda as well as Overseal, a UK-based concern that makes sweetener Talin.
Natraceutical also named Xavier Adsera its new president, replacing Vicente Dominguez who resigned from the post. Natraceutical posted a 7.7% jump to €904,000 in first-quarter net profits on flat revenues of €5.8m, boosted by higher operating margins.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
